Patients with 1 intermediate SVG lesion ( 30 % -60 % diameter stenosis ) were randomized to either stenting the SVG lesion with a paclitaxel-eluting stent ( PES group , n = 30 ) or to medical treatment alone ( MT group , n = 27 ) .